QA: Ernexa Therapeutics Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000748592_2016_Ernexa_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000748592, Ernexa Therapeutics Inc

  xvar xval
0 AssetsCurrent 9,110,000
1 IntangibleAssetsNetIncludingGoodwill 988,000
2 PropertyPlantAndEquipmentNet 3,915,000
3 remainder_Assets 2,395,000
4 LiabilitiesCurrent 5,122,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 7,438,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,089,130
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 13,545,459
11 remainder_Revenues 24,518,092
12 remainder_NetIncome -310,480
13 remainder_ComprehensiveNetIncome -1,529
  yvar yval
0 Assets 16,408,000
1 Liabilities 12,560,000
2 Expenses 31,634,589
3 Revenues 24,518,092
4 StockholdersEquity 3,848,000
5 NetIncome -7,426,977
6 ComprehensiveNetIncome -7,427,742
7 BaseVar 42,716,345
8 EconomicCapitalRatiobeforeLimitedLiability 0.0663
9 EconomicCapitalRatio 1.48

Edgar->Model Mapping

Feature Distribution

Change over Time